Home › Kanser sa Suso › Tennessee › Knoxville

Pag-aaral pangklinika para sa Kanser sa Suso sa Knoxville, TN

9 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Knoxville (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Nagre-recruitPhase 3

Tennessee Cancer Specialists, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06982521

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Nagre-recruitPhase 3

Tennessee Cancer Specialists ( Site 7001), Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

University of Tennessee Medical Center, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06618287

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Nagre-recruitPhase 3

Clinical Trial Site, Knoxville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07085767

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3

University of Tennessee - Knoxville, Knoxville

Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Nagre-recruitPhase 3

Tennessee Cancer Specialists, Knoxville

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

Nagre-recruitPhase 3

University of Tennessee - Knoxville, Knoxville

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3

University of Tennessee - Knoxville, Knoxville

Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy

Nagre-recruit

Thompson Proton Center, Knoxville

Edad 18 pataas · Kababaihan · Na-update Abr 8, 2025 · NCT06006806

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Knoxville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.